 |
This article relies largely or entirely on a single source. Relevant discussion may be found on the talk page. Please help improve this articlebyintroducing citations to additional sources.
Find sources: "Beta-D" – news · newspapers · books · scholar · JSTOR (July 2019) |
| |
| |
| Names | |
|---|---|
| Preferred IUPAC name
2-(3,4,5-Trimethoxyphenyl)(2,2-2H2)ethan-1-amine | |
| Other names
3,4,5-Trimethoxy-beta-dideuterophenethylamine | |
| Identifiers | |
| |
3D model (JSmol) |
|
| ChemSpider |
|
PubChem CID |
|
| UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
| Properties | |
| C11H15D2NO3 or C11H152H2NO3 | |
| Molar mass | 213.27 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
Beta-D (3,4,5-trimethoxy-β-dideuterophenethylamine) is a lesser-known psychedelic drug. It is one of the few phenethylamines used as a recreational drug that is enriched in deuterium. Beta-D can be prepared as a sulfate salt or as a hydrochloride salt. It is the beta-dideutero analogofmescaline. Beta-D was first synthesized by Alexander Shulgin. In his book PiHKAL, the dosage is listed as approximately 200–400 mg for the sulfate salt, and 178–356 mg for the hydrochloride salt. Its effects last for 12 hours. Beta-D has a very rapid onset. It produces an increased appreciation of music and a strong connection with God.[1] Very little data exists about the pharmacological properties, metabolism, and toxicity of Beta-D.
